Lv2
110 积分 2023-08-02 加入
Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections
1天前
已完结
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes
22天前
已完结
Expert consensus on the diagnosis and treatment of cutaneous nontuberculous mycobacterial diseases in China （2024）
22天前
已完结
Safety Division, Pharmaceutical and Medical safety Bureau, Ministry of Health and Welfare
1个月前
已完结
[Chinese expert consensus on the diagnosis and treatment of pneumonia in the elderly (2024 Edition)]
1个月前
已完结
Guidelines for the diagnosis and treatment of rosacea in China （2021 edition）
7个月前
已完结
Guideline for diagnosis and treatment of atopic dermatitis in China （2020）
8个月前
已完结
Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume
8个月前
已完结
Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial
8个月前
已完结
Comparative analysis of real‐world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims study
8个月前
已完结
皖公网安备34019202002308
